ubt251 vs retatrutide Mazdutide retatrutide: dual agonist meets triple agonist in the next-gen weight loss showdown retatrutide 2025 trial results The

Combined with exercise and a low-calorie diet, the Wegovy pill is intended for use in people with overweight, obesity, or weight-related medical problems, as well as to reduce the risk of major adverse cardiovascular events such as death, heart attack, or stroke in adults with overweight or obesity and heart disease

There are reports of persons using GLP-1 inhibitors losing their interest in alcohol, says Anne McTiernan, MD, PhD, an internist and epidemiologist at Fred Hutchinson Cancer Center in Seattle, who studies ways to prevent cancer through lifestyle changes like weight loss

Stick to the low-and-slow approach

The maintenance trial (NCT06859268) tests whether patients can reduce their retatrutide dose after achieving significant weight loss

Libido is often one of the first areas men notice changes, but its rarely the only one